Immunologix Teams with GenScript to Produce Human Antibody Therapeutics Ready for Clinical Trials
Summary
“This agreement is a win-win for both companies and we are happy to team up with GenScript to expand our capability and capacity.” “GenScript is pleased to form the strategic alliance with Immunologix, a world leader in human antibody therapeutics by novel approach.Immunologix captures billions of cells from each tonsil and processes them in its state of the art laboratory at the new SCRA Innovation Center at 645 Meeting Street in Charleston, SC.Jointly, the companies provide an integrated platform for discovery and development of full human therapeutic antibody candidates ready for clinical trials.“This relationship between Immunologix and GenScript has been building since initial discussions began in July 2010.“This agreement is a win-win for both companies and we are happy to team up with GenScript to expand our capability and capacity.”“GenScript is pleased to form the strategic alliance with Immunologix, a world leader in human antibody therapeutics by novel approach.Immunologix captures billions of cells from each tonsil and processes them in its state of the art laboratory at the new SCRA Innovation Center at 645 Meeting Street in Charleston, SC.GenScript, is a CRO specialized in biological research and drug discovery services.